Cargando…
Global transcriptomic study of circRNAs expression profile in sorafenib resistant hepatocellular carcinoma cells
The anti-angiogenic drugs represented by sorafenib over the years have always been the first-line treatment of hepatocellular carcinoma (HCC), but the drug resistance has always been a "bottleneck" in curative effect. Recently, aberrant expression of circular RNA (circRNA) is considered to...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086252/ https://www.ncbi.nlm.nih.gov/pubmed/32226514 http://dx.doi.org/10.7150/jca.39854 |